AChE-IN-120
AChE-IN-120 is a blood-brain barrier-permeable AChE inhibitor, with an IC50 of 0.91 μM and a Ki of 1.027 μM against human AChE. AChE-IN-120 exerts neuroprotective effects against oxidative damage. AChE-IN-120 can be used for the research of Alzheimer's disease.
For research use only. We do not sell to patients.
- Formula: C23H26FN5OS
- Molecular Weight:439.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
hAChE 0.91 μM (IC50) |
hAChE 1.027 μM (Ki) |
BuChE 30.97 μM (IC50) |
In Vitro
AChE-IN-120 (Compound 11e) (0-8 μM) potently and selectively inhibits human acetylcholinesterase (AChE) via a mixed-type inhibition mechanism, with an IC50 of 0.91 μM, while it only exhibits weak inhibitory activity against butyrylcholinesterase (BuChE) (IC50 = 30.97 μM)[1].
AChE-IN-120 (0.1-10 μM) exhibits low cytotoxicity against SH-SY5Y cells, and its viability inhibitory effect gradually weakens as the concentration decreases from 10 μM to 0.1 μM[1].
AChE-IN-120 (0.1-10 μM) exerts significant neuroprotective effects against H2O2-induced damage in SH-SY5Y cells at the concentration of 10 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 439.55
-
Formula C23H26FN5OS
-
SMILES
O=C1N(CC)C2=CC(F)=CC=C2/C1=N/NC(NC3CCN(CC3)CC4=CC=CC=C4)=S
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)